Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset, lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate: Efficacy and safety as an antidote. Is it accessible outside USA?

Lampropoulou DI, Laschos K, Amylidi AL, Angelaki A, Soupos N, Boumpoucheropoulos S, Papadopoulou E, Nanou E, Zidianakis V, Nasioulas G, Fildissis G, Aravantinos G.

J Oncol Pharm Pract. 2019 Aug 5:1078155219865597. doi: 10.1177/1078155219865597. [Epub ahead of print]

PMID:
31382864
2.

Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: a case report.

Agiannitopoulos K, Papadopoulou E, Tsaousis GN, Pepe G, Kampouri S, Kocdor MA, Nasioulas G.

BMC Med Genet. 2019 Jul 26;20(1):131. doi: 10.1186/s12881-019-0862-3.

3.

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer.

Fountzilas E, Kotoula V, Pentheroudakis G, Manousou K, Polychronidou G, Vrettou E, Poulios C, Papadopoulou E, Raptou G, Pectasides E, Karayannopoulou G, Chrisafi S, Papakostas P, Makatsoris T, Varthalitis I, Psyrri A, Samantas E, Bobos M, Christodoulou C, Papadimitriou C, Nasioulas G, Pectasides D, Fountzilas G.

ESMO Open. 2019 Mar 12;4(2):e000474. doi: 10.1136/esmoopen-2018-000474. eCollection 2019.

4.

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.

Tsaousis GN, Papadopoulou E, Apessos A, Agiannitopoulos K, Pepe G, Kampouri S, Diamantopoulos N, Floros T, Iosifidou R, Katopodi O, Koumarianou A, Markopoulos C, Papazisis K, Venizelos V, Xanthakis I, Xepapadakis G, Banu E, Eniu DT, Negru S, Stanculeanu DL, Ungureanu A, Ozmen V, Tansan S, Tekinel M, Yalcin S, Nasioulas G.

BMC Cancer. 2019 Jun 3;19(1):535. doi: 10.1186/s12885-019-5756-4.

5.

Clonal evolution of colorectal cancer in a patient with serially resected metastases and liquid biopsies: a case report and discussion of the literature.

Kastrisiou M, Zarkavelis G, Kampletsas E, Panopoulou E, Goussia A, Nasioulas G, Papadopoulou E, Tsaousi C, Pentheroudakis G.

ESMO Open. 2018 Jun 9;3(4):e000329. doi: 10.1136/esmoopen-2018-000329. eCollection 2018.

6.

Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece.

Mavroeidis L, Metaxa-Mariatou V, Papoudou-Bai A, Lampraki AM, Kostadima L, Tsinokou I, Zarkavelis G, Papadaki A, Petrakis D, Gκoura S, Kampletsas E, Nasioulas G, Batistatou A, Pentheroudakis G.

ESMO Open. 2018 Apr 6;3(3):e000335. doi: 10.1136/esmoopen-2018-000335. eCollection 2018.

7.

Expression of miR-208b and miR-499 in Greek Patients with Acute Myocardial Infarction.

Agiannitopoulos K, Pavlopoulou P, Tsamis K, Bampali K, Samara P, Nasioulas G, Mertzanos G, Babalis D, Lamnissou K.

In Vivo. 2018 Mar-Apr;32(2):313-318.

8.

Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center.

Apessos A, Agiannitopoulos K, Pepe G, Tsaousis GN, Papadopoulou E, Metaxa-Mariatou V, Tsirigoti A, Efstathiadou C, Markopoulos C, Xepapadakis G, Venizelos V, Tsiftsoglou A, Natsiopoulos I, Nasioulas G.

Cancer Genet. 2018 Jan;220:1-12. doi: 10.1016/j.cancergen.2017.10.002. Epub 2017 Oct 19.

PMID:
29310832
9.

Evidence for the efficacy of disulfiram and copper combination in glioblastoma multiforme - A propos of a case.

Karamanakos PN, Trafalis DT, Papachristou DJ, Panteli ES, Papavasilopoulou M, Karatzas A, Kardamakis D, Nasioulas G, Marselos M.

J BUON. 2017 Sep-Oct;22(5):1227-1232.

10.

Tumor molecular profiling of NSCLC patients using next generation sequencing.

Tsoulos N, Papadopoulou E, Metaxa-Mariatou V, Tsaousis G, Efstathiadou C, Tounta G, Scapeti A, Bourkoula E, Zarogoulidis P, Pentheroudakis G, Kakolyris S, Boukovinas I, Papakotoulas P, Athanasiadis E, Floros T, Koumarianou A, Barbounis V, Dinischiotu A, Nasioulas G.

Oncol Rep. 2017 Dec;38(6):3419-3429. doi: 10.3892/or.2017.6051. Epub 2017 Oct 23.

11.

Molecular predictive markers in tumors of the gastrointestinal tract.

Papadopoulou E, Metaxa-Mariatou V, Tsaousis G, Tsoulos N, Tsirigoti A, Efstathiadou C, Apessos A, Agiannitopoulos K, Pepe G, Bourkoula E, Nasioulas G.

World J Gastrointest Oncol. 2016 Nov 15;8(11):772-785. Review.

12.

Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients.

Papadopoulou E, Tsoulos N, Tsirigoti A, Apessos A, Agiannitopoulos K, Metaxa-Mariatou V, Zarogoulidis K, Zarogoulidis P, Kasarakis D, Kakolyris S, Dahabreh J, Vlastos F, Zoublios C, Rapti A, Papageorgiou NG, Veldekis D, Gaga M, Aravantinos G, Karavasilis V, Karagiannidis N, Nasioulas G.

Oncol Lett. 2015 Oct;10(4):2176-2184. Epub 2015 Aug 12.

13.

KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study.

Negru S, Papadopoulou E, Apessos A, Stanculeanu DL, Ciuleanu E, Volovat C, Croitoru A, Kakolyris S, Aravantinos G, Ziras N, Athanasiadis E, Touroutoglou N, Pavlidis N, Kalofonos HP, Nasioulas G.

BMJ Open. 2014 May 23;4(5):e004652. doi: 10.1136/bmjopen-2013-004652.

14.

Sensitization of (colon) cancer cells to death receptor related therapies: a report from the FP6-ONCODEATH research consortium.

Pintzas A, Zhivotovsky B, Workman P, Clarke PA, Linardopoulos S, Martinou JC, Lacal JC, Robine S, Nasioulas G, Andera L.

Cancer Biol Ther. 2012 May;13(7):458-66. doi: 10.4161/cbt.19600. Epub 2012 May 1. Review.

PMID:
22406997
15.

Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families.

Thodi G, Fostira F, Sandaltzopoulos R, Nasioulas G, Grivas A, Boukovinas I, Mylonaki M, Panopoulos C, Magic MB, Fountzilas G, Yannoukakos D.

BMC Cancer. 2010 Oct 11;10:544. doi: 10.1186/1471-2407-10-544.

16.

Elucidation of the transmission of a novel mutation in BRCA1 (1125delCT) in a family with multiple cases of breast cancer.

Razis E, Belogianni I, Siamanta V, Apessos A, Kyriakopoulou V, Papadopoulou E, Sariyanni M, Theofilopoulos D, Labropoulos S, Nasioulas G.

Cancer Genomics Proteomics. 2009 Jul-Aug;6(4):215-7.

17.

Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.

Triantafillidis JK, Nasioulas G, Kosmidis PA.

Anticancer Res. 2009 Jul;29(7):2727-37. Review.

18.

NRAMP1 polymorphism and viral factors in Sardinian multiple sclerosis patients.

Gazouli M, Sechi L, Paccagnini D, Sotgiu S, Arru G, Nasioulas G, Vassilopoulos D.

Can J Neurol Sci. 2008 Sep;35(4):491-4.

PMID:
18973068
19.

Culture of primary epithelial adenoma cells from familial adenomatous polyposis patients.

Fostira F, Apessos A, Oikonomou E, Kouklis P, Baratsis S, Manifikos G, Andera L, Yannoukakos D, Pintzas A, Nasioulas G.

Anticancer Res. 2008 Mar-Apr;28(2A):843-6.

20.

Inherited cancer predisposition syndromes in Greece.

Apessos A, Papadopoulou E, Belogianni I, Baratsis S, Triantafillidis JK, Kosmidis P, Karydas E, Briasoulis E, Pisiotis C, Papazisis K, Nasioulas G.

Anticancer Res. 2008 Mar-Apr;28(2B):1341-7. Review.

21.

The functional polymorphisms of NRAMP1 gene in Greeks with sarcoidosis.

Gazouli M, Koundourakis A, Ikonomopoulos J, Gialafos EJ, Papaconstantinou I, Nasioulas G, Lukas JC, Gorgoulis VG.

Sarcoidosis Vasc Diffuse Lung Dis. 2007 Sep;24(2):153-4. No abstract available.

PMID:
18496987
22.

Role of functional polymorphisms of NRAMP1 gene for the development of Crohn's disease.

Gazouli M, Atsaves V, Mantzaris G, Economou M, Nasioulas G, Evangelou K, Archimandritis AJ, Anagnou NP.

Inflamm Bowel Dis. 2008 Oct;14(10):1323-30. doi: 10.1002/ibd.20488.

PMID:
18454481
23.

BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort.

Goutas N, Vlachodimitropoulos D, Bouka M, Lazaris AC, Nasioulas G, Gazouli M.

Anticancer Res. 2008 Jan-Feb;28(1A):305-8.

24.

Different intrafamilial clinical presentation of FMF mutation carriers.

Chalevelakis G, Apostolakis I, Koliou X, Apessos A, Kyriakopoulou V, Vrakidou E, Vasilopoulou A, Lamnisou K, Nasioulas G.

Genet Test. 2008 Mar;12(1):125-7. doi: 10.1089/gte.2007.0068.

PMID:
18318646
25.

Heterogeneous molecular mechanisms underlie attenuated familial adenomatous polyposis.

Cattaneo F, Molatore S, Mihalatos M, Apessos A, Venesio T, Bione S, Grignani P, Nasioulas G, Ranzani GN.

Genet Med. 2007 Dec;9(12):836-41.

PMID:
18091433
26.

G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history.

Anagnostopoulos T, Pertesi M, Konstantopoulou I, Armaou S, Kamakari S, Nasioulas G, Athanasiou A, Dobrovic A, Young MA, Goldgar D, Fountzilas G, Yannoukakos D.

Breast Cancer Res Treat. 2008 Jul;110(2):377-85. Epub 2007 Sep 28.

PMID:
17902052
27.

Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo.

Oikonomou E, Kothonidis K, Taoufik E, Probert E, Zografos G, Nasioulas G, Andera L, Pintzas A.

Br J Cancer. 2007 Jul 2;97(1):73-84. Epub 2007 Jun 5. Erratum in: Br J Cancer. 2007 Dec 17;97(12):1716. Taoufik,E [added]; Probert, E [added].

28.

Molecular characterization of the Anopheles maculipennis complex during surveillance for the 2004 Olympic Games in Athens.

Patsoula E, Samanidou-Voyadjoglou A, Spanakos G, Kremastinou J, Nasioulas G, Vakalis NC.

Med Vet Entomol. 2007 Mar;21(1):36-43.

PMID:
17373945
29.

Cell-free DNA and RNA in plasma as a new molecular marker for prostate and breast cancer.

Papadopoulou E, Davilas E, Sotiriou V, Georgakopoulos E, Georgakopoulou S, Koliopanos A, Aggelakis F, Dardoufas K, Agnanti NJ, Karydas I, Nasioulas G.

Ann N Y Acad Sci. 2006 Sep;1075:235-43.

PMID:
17108217
30.

Novel germline mutations in the APC gene of Cypriot patients with familial and sporadic adenomatous polyposis.

Hadjisavvas A, Papasavva T, Loizidou M, Malas S, Potamitis G, Christodoulou C, Pavlides G, Papamichael D, Klonis C, Nasioulas G, Anastasiadou V, Kyriacou K.

Clin Genet. 2006 May;69(5):404-9.

PMID:
16650078
31.

Prenatal diagnosis of hypochondroplasia: report of two cases.

Karadimas C, Sifakis S, Valsamopoulos P, Makatsoris C, Velissariou V, Nasioulas G, Petersen MB, Koumantakis E, Hatzaki A.

Am J Med Genet A. 2006 May 1;140(9):998-1003.

PMID:
16575888
32.

Molecular and morphological characterization of Aedes albopictus in northwestern Greece and differentiation from Aedes cretinus and Aedes aegypti.

Patsoula E, Samanidou-Voyadjoglou A, Spanakos G, Kremastinou J, Nasioulas G, Vakalis NC.

J Med Entomol. 2006 Jan;43(1):40-54.

PMID:
16506446
33.

Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease.

Gazouli M, Mantzaris G, Archimandritis AJ, Nasioulas G, Anagnou NP.

World J Gastroenterol. 2005 Dec 21;11(47):7525-30.

34.

Subtype C1 persistent infection of HHV-8 in a PEL patient.

Metaxa-Mariatou V, Papaioannou D, Loli A, Papadopoulou I, Gazouli M, Mavroudis P, Nasioulas G.

Leuk Lymphoma. 2005 Oct;46(10):1507-12.

PMID:
16194897
35.

Efficient testing of the RET gene by DHPLC analysis for MEN 2 syndrome in a cohort of patients.

Pazaitou-Panayiotou K, Kaprara A, Sarika L, Zovoilis T, Belogianni I, Vainas I, Nasioulas G.

Anticancer Res. 2005 May-Jun;25(3B):2091-5.

36.

Prevalence of human herpesvirus 8 DNA sequences in human immunodeficiency virus-negative individuals without Kaposi's sarcoma in Greece.

Zavos G, Gazouli M, Papaconstantinou I, Lukas JC, Zografidis A, Kostakis A, Nasioulas G.

In Vivo. 2005 Jul-Aug;19(4):729-32.

37.

Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients.

Mihalatos M, Apessos A, Dauwerse H, Velissariou V, Psychias A, Koliopanos A, Petropoulos K, Triantafillidis JK, Danielidis I, Fountzilas G, Agnantis NJ, Nasioulas G.

BMC Cancer. 2005 Apr 15;5:40.

38.

hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients.

Apessos A, Mihalatos M, Danielidis I, Kallimanis G, Agnantis NJ, Triantafillidis JK, Fountzilas G, Kosmidis PA, Razis E, Georgoulias VA, Nasioulas G.

Br J Cancer. 2005 Jan 31;92(2):396-404.

39.

Molecular analysis of GISTs: evaluation of sequencing and dHPLC.

Metaxa-Mariatou V, Papadopoulos S, Papadopoulou E, Passa O, Georgiadis T, Arapadoni-Dadioti P, Leondara V, Nasioulas G.

DNA Cell Biol. 2004 Nov;23(11):777-82.

PMID:
15585136
40.

Cell-free DNA and RNA in plasma as a new molecular marker for prostate cancer.

Papadopoulou E, Davilas E, Sotiriou V, Koliopanos A, Aggelakis F, Dardoufas K, Agnanti NJ, Karydas I, Nasioulas G.

Oncol Res. 2004;14(9):439-45.

PMID:
15490975
41.

The implications of using mutagenic primers in combination with Taq polymerase having proofreading activity.

Papadopoulou E, Metaxa-Mariatou V, Hatzaki A, Hatzis T, Nasioulas G.

Biologicals. 2004 Jun;32(2):84-7.

PMID:
15454186
42.

Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer.

Belogianni I, Apessos A, Mihalatos M, Razi E, Labropoulos S, Petounis A, Gaki V, Keramopoulos A, Pandis N, Kyriacou K, Hadjisavvas A, Kosmidis P, Yannoukakos D, Nasioulas G.

BMC Cancer. 2004 Sep 7;4:61.

43.

Lack of association between RNASEL Arg462Gln variant and the risk of breast cancer.

Sevinç A, Yannoukakos D, Konstantopoulou I, Manguoglu E, Lüleci G, Colak T, Akyerli C, Colakoglu G, Tez M, Sayek I, Gerassimos V, Nasioulas G, Papadopoulou E, Florentin L, Kontogianni E, Bozkurt B, Kocabas NA, Karakaya AE, Yulug IG, Ozçelik T.

Anticancer Res. 2004 Jul-Aug;24(4):2547-9.

44.

Human herpesvirus type 8 genotypes in iatrogenic, classic and AIDS-associated Kaposi's sarcoma from Greece.

Gazouli M, Papaconstantinou I, Zavos G, Metaxa-Mariatou V, Nasioulas G, Boletis J, Arapadoni-Dadioti P, Giaslakiotis K, Zografidis A, Kostakis A.

Anticancer Res. 2004 May-Jun;24(3a):1597-602.

45.

The role of collagen IX tryptophan polymorphisms in symptomatic intervertebral disc disease in Southern European patients.

Kales SN, Linos A, Chatzis C, Sai Y, Halla M, Nasioulas G, Christiani DC.

Spine (Phila Pa 1976). 2004 Jun 1;29(11):1266-70.

PMID:
15167667
46.

Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors.

Ioannidis P, Kottaridi C, Dimitriadis E, Courtis N, Mahaira L, Talieri M, Giannopoulos A, Iliadis K, Papaioannou D, Nasioulas G, Trangas T.

Cancer Lett. 2004 Jun 25;209(2):245-50.

PMID:
15159028
47.

The 500-base-pair fragment of the putative gene RvD1-Rv2031c is also present in the genome of Mycobacterium tuberculosis.

Metaxa-Mariatou V, Vakalis N, Gazouli M, Nasioulas G.

In Vivo. 2004 Jan-Feb;18(1):33-5.

48.

Molecular analysis of Kaposi's sarcoma occurring during haemodialysis.

Metaxa-Mariatou V, Chiras T, Loli A, Gazouli M, Vallis D, Nasioulas G.

Clin Exp Dermatol. 2004 Mar;29(2):188-91.

PMID:
14987280
49.

Documentation of Legionella pneumophila and Mycobacterium tuberculosis co-existence in a patient with acute respiratory distress syndrome.

Metaxa-Mariatou V, Ikonomou A, Tzortzi A, Mihalatos M, Vakalis N, Nasioulas G.

In Vivo. 2003 Jul-Aug;17(4):365-7.

PMID:
12929592
50.

Elucidation of cytomegalovirus disease recurrence in an HIV-1-positive patient.

Kottaridi C, Ploumidis G, Grapsas E, Feretis C, Benakis P, Filalithis P, Bouzarelou D, Nasioulas G.

J Gastroenterol. 2003;38(7):643-6.

PMID:
12898356

Supplemental Content

Loading ...
Support Center